Clinical Trial Update: Evaluation of Risk Minimization, Assessment and Outcomes in Patients With Chronic Pain Taking Avinza [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating risk minimization, assessment, and outcomes in patients with chronic pain taking Avinza (morphine sulfate extended-release).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Avinza (morphine sulfate extended-release)

Snippet

Sponsor: Pfizer | Conditions: Pain | Phase 4 | Status: COMPLETED | Results posted: 2010-02-15